Description
KADCYLA® 160 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)
059M91 SSA IV
Cada frasco contiene 1500 UI de factor VIII recombinante
La dosis y frecuencia dependen del esquema de inicio y mantenimiento
PRESENTACIÓN: 1 CAJA
CRESTOR TAB. 40 MG. CAJA C/30 BETAMETASONA 0.75 MG INDOMETACINA 25.00 MG METOCARBAMOL 215.00 MG KADCYLA® 160 mg es unSUSTANCIA: CRESTOR TAB. 40 MG. CAJA C 30 FABRICANTE: ASTRA ZENECA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
